Keros Therapeutics Reports Recent Business Highlights and Fo

LEXINGTON, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat

Related Keywords

Jasbirs Seehra , Justin Frantz , Company Quarterly Report On Form , Hansoh Shanghai Healthtech Co Ltd , Keros Therapeutics Inc , Exchange Commission , Company Nasdaq , Program Milestones , Chief Executive , Corporate Highlights , Anticipated Program Milestones , Keros Therapeutics , Private Securities Litigation Reform Act , Quarterly Report , Region ,